Rothschild Investment LLC’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-23,500
Closed -$152K 479
2023
Q2
$152K Sell
23,500
-6,800
-22% -$44K 0.01% 463
2023
Q1
$228K Sell
30,300
-4,800
-14% -$36.1K 0.02% 428
2022
Q4
$356K Sell
35,100
-6,600
-16% -$66.9K 0.03% 343
2022
Q3
$412K Buy
41,700
+8,700
+26% +$86K 0.04% 306
2022
Q2
$351K Hold
33,000
0.03% 349
2022
Q1
$322K Buy
33,000
+7,000
+27% +$68.3K 0.03% 383
2021
Q4
$372K Buy
+26,000
New +$372K 0.03% 371